Meet MARRVEL AI, a cutting-edge machine-learning platform designed to transform genetic analysis by enhancing precision, speed, and efficiency.
01
MARRVEL AI combines the extensive data housed in the MARRVEL database with proprietary AI algorithms to automate and accelerate variant analysis. Our platform identifies, filters, and prioritizes genetic variants with unmatched accuracy, providing precise insights into rare and complex cases.
02
Through comprehensive variant annotation, MARRVEL AI prioritizes potential pathogenic variants by aggregating key information from multiple human genetics databases and integrating phenotypic data. This process reduces diagnostic bottlenecks, helping users quickly identify disease-causing variants that other tools may overlook.
03
A unique feature of MARRVEL AI is its ability to leverage genetic data across multiple species. By aligning human variants with data from model organisms, such as yeast, mouse, and zebrafish, MARRVEL AI deepens analysis by examining conservation across species. This cross-species approach helps validate findings and supports the selection of appropriate models for experimental studies.
04
MARRVEL AI offers extensive customization options, giving users control over data quality, relevance, and specific analysis parameters. This adaptability allows researchers to address common challenges, providing precise, tailored analysis that meets diverse clinical and research needs.
05
Recognizing the importance of data sovereignty, MARRVEL AI can be deployed on-premises. This ensures compliance with data privacy regulations while maintaining high-speed performance, making MARRVEL AI ideal for large-scale analyses in diverse healthcare and research environments.
Independent studies have shown that MARRVEL AI achieves up to twice the accuracy of top competitors.
Designed for cost-effectiveness, delivering up to 50% savings per case compared to current platforms.
Advanced tools analyze complex data, streamline workflows and uncover breakthrough insights.
Experience rapid turnaround times, enabling faster decision-making and accelerating your research and clinical workflows.
Using cutting edge AI, we unlock the power of unstructured data to identify new disease causing genes.
Identify actionable genetic variants with precision and speed, enabling companies to streamline pipelines and uncover novel therapeutic opportunities.
Since our publication in the New England Journal of Medicine AI, MARRVEL has seen positive reception and coverage.